Simplex Trading
FULC icon

Simplex Trading’s Fulcrum Therapeutics FULC Stock Holding History

Simplex Trading’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Buy
91,900
+61,400
+201% +$373K ﹤0.01% 4094
2026
Q1 		$234K Buy
30,500
+15,600
+105% +$145K ﹤0.01% 4118
2025
Q4 		$169K Buy
+14,900
New +$152K ﹤0.01% 4407
2025
Q1 		– Sell
-9,900
Closed -$46K – 8860
2024
Q4 		$46K Sell
9,900
-187,600
-95% -$692K ﹤0.01% 5962
2024
Q3 		$705K Buy
197,500
+194,000
+5,543% +$1.44M ﹤0.01% 3248
2024
Q2 		$21K Buy
3,500
+2,500
+250% +$18.9K ﹤0.01% 6850
2024
Q1 		$9K Buy
+1,000
New +$8.93K ﹤0.01% 7671
2023
Q4 		– Sell
-89,700
Closed -$398K – 9135
2023
Q3 		$398K Buy
89,700
+76,500
+580% +$334K ﹤0.01% 3644
2023
Q2 		$43K Buy
13,200
+11,200
+560% +$32.9K ﹤0.01% 5989
2023
Q1 		$5K Sell
2,000
-5,600
-74% -$50.2K ﹤0.01% 8037
2022
Q4 		$55K Buy
7,600
+2,300
+43% +$15K ﹤0.01% 5753
2022
Q3 		$42K Buy
5,300
+2,700
+104% +$19.3K ﹤0.01% 6671
2022
Q2 		$12K Sell
2,600
-16,100
-86% -$157K ﹤0.01% 8119
2022
Q1 		$442K Buy
18,700
+17,900
+2,238% +$253K ﹤0.01% 3990
2021
Q4 		$14K Buy
+800
New +$15.8K ﹤0.01% 8741

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Simplex Trading's FULC Position: Q2 2026 in Review

Simplex Trading sold out of Fulcrum Therapeutics (FULC) in Q2 2026, closing a stake of 41,940 shares — an estimated $255K sold.

Simplex Trading first reported a position in FULC in Q1 2022 and held it in 14 quarters. The position peaked at $752K in Q2 2025. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Simplex Trading reported no remaining Fulcrum Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 41,940 Fulcrum Therapeutics shares in Q2 2026, an estimated $255K.
  • Simplex Trading first reported a position in Fulcrum Therapeutics in Q1 2022 and held it in 14 quarters.
  • Simplex Trading's Fulcrum Therapeutics position peaked at $752K in Q2 2025.
  • 155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.